AKT1 and ovarian carcinoma: Our previous findings showed that COL11A1 confers resistance to cisplatin and paclitaxel in ovarian cancer cells via increased Akt phosphorylation22, and that COL11A1 regulates TWIST1 and Mcl-1 to induce chemoresistance and inhibit apoptosis23.